LFCR
Lifecore Biomedical's Momentum Continues: Q4 2025 Earnings Exceed Expectations
The recent earnings conference call held by Lifecore Biomedical provided a comprehensive update on the company's financial performance for the Q4 and transition period ended December 31st, 2025. The call was led by Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. During the